Ken Fujise

1.7k total citations
44 papers, 1.3k citations indexed

About

Ken Fujise is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, Ken Fujise has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 15 papers in Cardiology and Cardiovascular Medicine and 12 papers in Molecular Biology. Recurrent topics in Ken Fujise's work include Coronary Interventions and Diagnostics (9 papers), Acute Myocardial Infarction Research (7 papers) and Microbial Metabolism and Applications (4 papers). Ken Fujise is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Acute Myocardial Infarction Research (7 papers) and Microbial Metabolism and Applications (4 papers). Ken Fujise collaborates with scholars based in United States, Thailand and Canada. Ken Fujise's co-authors include Di Zhang, Richard W. Smalling, Decha Pinkaew, Zakar Mnjoyan, Amornrat Phongdara, George Schroth, H. Vernon Anderson, Potchanapond Graidist, Di Zhang and Douglas A. Weidner and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Nature Communications.

In The Last Decade

Ken Fujise

43 papers receiving 1.2k citations

Peers

Countries citing papers authored by Ken Fujise

Since Specialization

Citations

This map shows the geographic impact of Ken Fujise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Fujise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Fujise more than expected).

Fields of papers citing papers by Ken Fujise

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ken Fujise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Fujise. The network helps show where Ken Fujise may publish in the future.

Co-authorship network of co-authors of Ken Fujise

This figure shows the co-authorship network connecting the top 25 collaborators of Ken Fujise. A scholar is included among the top collaborators of Ken Fujise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ken Fujise. Ken Fujise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fortilin binds CTNNA3 and protects it against phosphorylation, ubiquitination, and proteasomal degradation to guard cells against apoptosis 2025 ·Communications Biology ·(unknown), Decha Pinkaew, (unknown), (unknown), HoangDinh Huynh, Lena Tanaka, Ken Fujise	4
2	Fortilin deficiency induces anti-atherosclerotic phenotypes in macrophages and protects hypercholesterolemic mice against atherosclerosis 2025 ·Communications Biology ·(unknown), Decha Pinkaew, (unknown), Preedakorn Chunhacha, (unknown), (unknown), (unknown), Hasseri Halim, Yuhong Wei, Lena Tanaka, HoangDinh Huynh, Kota V. Ramana, Shi‐You Chen, Rebecca A. Ihrie, Ken Fujise	0
3	ADAR1 exacerbates ischemic brain injury via astrocyte-mediated neuron apoptosis 2023 ·Redox Biology ·Dunpeng Cai, (unknown), Ken Fujise, Shi‐You Chen	24
4	A Commentary on the Effect of Targeted Temperature Management in Patients Resuscitated from Cardiac Arrest 2022 ·Therapeutic Hypothermia and Temperature Management ·Michael Hölzer, Jeanne E. Poole, Jean-Baptiste Lascarrou, Ken Fujise, Graham Nichol	3
5	Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies 2021 ·Protein Expression and Purification ·(unknown), (unknown), Xinzhu Pu, Matthew Turner, (unknown), Ken Fujise, Owen M. McDougal, Lisa Warner	3
6	Fortilin inhibits p53, halts cardiomyocyte apoptosis, and protects the heart against heart failure 2021 ·Cell Death Discovery ·Preedakorn Chunhacha, Decha Pinkaew, (unknown), Dawn E. Bowles, Ken Fujise	10
7	Ticagrelor induces paraoxonase-1 (PON1) and better protects hypercholesterolemic mice against atherosclerosis compared to clopidogrel 2019 ·PLoS ONE ·Hasseri Halim, Decha Pinkaew, Preedakorn Chunhacha, (unknown), Perumal Thiagarajan, Ken Fujise	15
8	Comparative Outcomes of Transapical Versus Transfemoral Access for Transcatheter Aortic Valve Replacement in Diabetics 2019 ·Cardiology and Therapy ·Ayman Elbadawi, Ahmed H. Mohamed, Islam Y. Elgendy, Gbolahan Ogunbayo, Michael Megaly, Hend I. Shahin, Karim Mahmoud, Mohamed Omer, Ahmed Abuzaid, Ken Fujise, (unknown)	2
9	Symptomatic Patent Foramen Ovale with Hemidiaphragm Paralysis 2017 ·Case Reports in Pulmonology ·(unknown), (unknown), Shawn Nishi, Ken Fujise, (unknown)	1
10	Fortilin binds IRE1α and prevents ER stress from signaling apoptotic cell death 2017 ·Nature Communications ·Decha Pinkaew, Abhijnan Chattopadhyay, Matthew D. King, Preedakorn Chunhacha, Zhihe Liu, Heather L. Stevenson, Yanjie Chen, (unknown), Owen M. McDougal, Ken Fujise	63
11	Abstract 50: Use of Impella Ventricular Assist Device in Patients with Severe Coronary Artery Disease Presenting with Cardiac Arrest 2011 ·Circulation ·(unknown), Qiangjun Cai, Syed Amir Gilani, Ken Fujise, Alejandro Barbagelata	1
12	Congenital coronary artery fistula presenting later in life 2011 ·Journal of Cardiology Cases ·(unknown), (unknown), (unknown), Parham Parto, (unknown), Ken Fujise	7
13	Embryonic lethality of fortilin-null mutant mice by BMP-pathway overactivation 2009 ·Biochimica et Biophysica Acta (BBA) - General Subjects ·Yuichi Koide, Tomomi Kiyota, (unknown), Decha Pinkaew, Zhihe Liu, Yoichi Kato, Nongporn Hutadilok‐Towatana, Amornrat Phongdara, Ken Fujise	30
14	Antiapoptotic Protein Partners Fortilin and MCL1 Independently Protect Cells from 5-Fluorouracil-induced Cytotoxicity 2004 ·Journal of Biological Chemistry ·Potchanapond Graidist, Amornrat Phongdara, Ken Fujise	56
15	Physical and Functional Interaction between Myeloid Cell Leukemia 1 Protein (MCL1) and Fortilin 2002 ·Journal of Biological Chemistry ·Di Zhang, (unknown), Douglas A. Weidner, Zakar Mnjoyan, Ken Fujise	132
16	Risk assessment of slow or no‐reflow phenomenon in aortocoronary vein graft percutaneous intervention 2001 ·Catheterization and Cardiovascular Interventions ·Stefano Sdringola, Abid Assali, (unknown), Ali Moustapha, (unknown), Salim Yusuf, Ken Fujise, Oscar Rosales, George Schroth, H. Vernon Anderson, Richard W. Smalling	42
17	Characterization of Fortilin, a Novel Antiapoptotic Protein 2001 ·Journal of Biological Chemistry ·(unknown), Di Zhang, Ken Fujise	247
18	Causes of early reintervention after successful coronary artery stenting 2000 ·The American Journal of Cardiology ·Abid Assali, Stefano Sdringola, Mohammad Ghani, Ali Moustapha, H. Vernon Anderson, George Schroth, Ken Fujise, Richard W. Smalling, Oscar Rosales	5
19	Intracoronary adenosine administered during rotational atherectomy of complex lesions in native coronary arteries reduces the incidence of no-reflow phenomenon 1999 ·Catheterization and Cardiovascular Interventions ·George P. Hanna, (unknown), Ken Fujise, George Schroth, (unknown), H. Vernon Anderson, Richard W. Smalling	41
20	Infrapopliteal Transcatheter Interventions for Limb Salvage in Diabetic Patients: Importance of Aggressive Interventional Approach and Role of Transcutaneous Oximetry 1997 ·Journal of the American College of Cardiology ·George P. Hanna, Ken Fujise, Olle Kjellgren, Steven Feld, Caroline E. Fife, George Schroth, Thomas O. Clanton, Vernon Anderson, Richard W. Smalling	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact